These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2103752)

  • 21. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of secretin to stimulate gastrin release and adenylate cyclase activity in gastrinoma in vitro.
    Ellison EC; O'Dorisio MS; O'Dorisio T; Sparks J; Vasallo L; Woltering EA
    Surgery; 1984 Dec; 96(6):1019-26. PubMed ID: 6095476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
    Lamers CG; Van Tongeren JH
    Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower esophageal sphincter responses to enteric hormones in two patients with Zollinger-Ellison syndrome.
    Wu WC; Hogan WJ; Whalen GE; Hoke SE; Go VL; Kalkhoff RK
    Am J Dig Dis; 1975 Aug; 20(8):716-20. PubMed ID: 1155411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of secretin on circulating gastrin.
    Thompson JC; Reeder DD; Bunchman HH; Becker HD; Brandt EN
    Ann Surg; 1972 Sep; 176(3):384-93. PubMed ID: 5073222
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis of gastrinoma by the secretin suppression test.
    Bradley EL; Galambos JT
    Surg Gynecol Obstet; 1976 Nov; 143(5):784-8. PubMed ID: 982259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric juice as gastrin-releasing factor in the Zollinger-Ellison syndrome.
    Stadil F; Rehfeld JF; Thaysen EH
    Lancet; 1971 Jul; 2(7715):102. PubMed ID: 4103967
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
    Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
    Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of secretin on plasma gastrin in the Zollinger-Ellison syndrome.
    Schrumpf E; Petersen H; Berstad A; Myren J; Rosenlund B
    Scand J Gastroenterol; 1973; 8(2):145-50. PubMed ID: 4697075
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995).
    Ellison EC; Gower WR; Elkhammas E; Woltering EA; Sparks J; O'Dorisio TM; Fabri PJ
    Am J Med; 1986 Dec; 81(6B):56-64. PubMed ID: 2879448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
    Rigaud D; Accary JP; Mignon M; Bonfils S
    Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrin and secretin radioimmunoassay in diagnosis and therapy of acid-peptic disease.
    Straus E; Greenstein RJ; Yalow RS
    Mt Sinai J Med; 1979; 46(2):87-90. PubMed ID: 312455
    [No Abstract]   [Full Text] [Related]  

  • 34. The Zollinger-Ellison syndrome--23 years later.
    Deveney CW; Deveney KS; Way LW
    Ann Surg; 1978 Sep; 188(3):384-93. PubMed ID: 686901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients.
    Dockray GJ; Walsh JH
    Gastroenterology; 1975 Feb; 68(2):222-30. PubMed ID: 1116670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a human gastrinoma in nude mice.
    Upp JR; Trudel JL; Townsend CM; Alexander RW; Rajaraman S; Nealon WH; Greeley GH; Thompson JC
    Surgery; 1988 Dec; 104(6):1037-45. PubMed ID: 3194831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome.
    Fallucca F; Delle Fave G; Giangrande L; Del Balzo P; De Magistris L; Carratù R
    J Endocrinol Invest; 1981; 4(4):451-3. PubMed ID: 6120969
    [No Abstract]   [Full Text] [Related]  

  • 38. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome.
    Brady CE
    Am J Gastroenterol; 1991 Feb; 86(2):129-34. PubMed ID: 1992623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability of serum gastrin levels in Zollinger-Ellison syndrome. Studies with two antisera to gastrin.
    Ivey KJ; Hansky J
    Am J Dig Dis; 1975 Jun; 20(6):513-17. PubMed ID: 1130377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of commercially available antibodies used for gastrin measurement.
    Wolfe MM; Paquet RJ; Reel GM
    J Lab Clin Med; 1985 Apr; 105(4):417-21. PubMed ID: 3981055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.